InvestorsHub Logo
Post# of 252695
Next 10
Followers 2
Posts 660
Boards Moderated 0
Alias Born 10/30/2004

Re: DewDiligence post# 30793

Saturday, 07/01/2006 2:08:00 AM

Saturday, July 01, 2006 2:08:00 AM

Post# of 252695
Re Talecris:

"Individuals with selective IgA deficiencies who have known antibody against IgA should not receive Prolastin®, since these patients may experience severe reactions, including anaphylaxis, to IgA which may be present. "

What is their process for purification of plasma AAT, immunoprecipitation? Affinity chromatography? To know to degree to which they can expand the current supply, we need to know the current efficiency of purification.

The obstacle to discovery is the illusion of knowledge.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.